NOBILIS ERYSIPELAS
NOBILIS ERYSIPELAS
Not authorised
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Product identification
Medicine name:
NOBILIS ERYSIPELAS
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Target species:
-
Turkey
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Turkey
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2632747 5/1997
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 10/02/2023
How useful was this page?:
